NCT03017352View on ClinicalTrials.gov

Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Exenatide

DRUG

Placebos

Trial Locations (1)

2820

Steno Diabetes Center Copenhagen, Gentofte Municipality

All Listed Sponsors
collaborator

Steno Diabetes Center Copenhagen

OTHER

lead

Filip Krag Knop

OTHER

NCT03017352 - Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases | Biotech Hunter | Biotech Hunter